4//SEC Filing
Grimes Scott D. 4
Accession 0001666071-22-000034
CIK 0001666071other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 4:55 PM ET
Size
14.2 KB
Accession
0001666071-22-000034
Insider Transaction Report
Form 4
Cardlytics, Inc.CDLX
Grimes Scott D.
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2022-04-01+14,920→ 230,608 total - Sale
Common Stock
2022-04-04$56.40/sh−2,500$141,000→ 228,108 total - Sale
Common Stock
2022-04-04$57.40/sh−3,100$177,940→ 225,008 total - Sale
Common Stock
2022-04-04$58.09/sh−400$23,236→ 224,608 total - Exercise/Conversion
Restricted Stock Units
2022-04-01−14,920→ 29,840 total→ Common Stock (14,920 underlying)
Holdings
- 55,832(indirect: See Footnote)
Common Stock
- 53,112(indirect: See Footnote)
Common Stock
Footnotes (9)
- [F1]Represents the underlying vested shares of common stock of the Issuer which have not been delivered.
- [F2]These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2020, as amended September 15, 2021.
- [F3]The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $55.91 to $56.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4) and (5) to this Form 4.
- [F4]The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $56.93 to $57.90, inclusive.
- [F5]The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $58.05 to $58.17, inclusive.
- [F6]The reportable securities are held by the 2013 Scott Grimes GRAT UAD.
- [F7]The reportable securities are held by the UTMA Custodial account fbo Pierce Grimes.
- [F8]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
- [F9]The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date.
Documents
Issuer
Cardlytics, Inc.
CIK 0001666071
Entity typeother
Related Parties
1- filerCIK 0001617486
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 4:55 PM ET
- Size
- 14.2 KB